2012
DOI: 10.1258/vasc.2011.201201
|View full text |Cite
|
Sign up to set email alerts
|

Biology of metabolic syndrome in a vascular patient

Abstract: Metabolic syndrome is highly prevalent in vascular patients and has a significant impact on the outcomes of vascular interventions. It comprises of a set of metabolically driven risk factors, including truncal obesity, dyslipidemia, elevated blood pressure and elevated fasting blood glucose. Increased insulin resistance within the context of obesity and hypertension contributes to atherogenic dyslipidemia, hyperglycemia, and prothrombotic and proinflammatory states which lead to the adverse impact of m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 113 publications
(128 reference statements)
0
5
0
Order By: Relevance
“…While the mechanism underlying metabolic syndrome is poorly understood, insulin resistance appears to be an important factor [ 2 ]. The occurrence of hyperglycemia, dyslipidemia, and hypertension in metabolic syndrome is associated with endothelial dysfunction and promotion of atherogenesis [ 3 ]. These changes show that patients with metabolic syndrome have an increased risk of myocardial infarction and stroke [ 4 , 5 ], which, together, contribute to the burden of non-communicable diseases [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…While the mechanism underlying metabolic syndrome is poorly understood, insulin resistance appears to be an important factor [ 2 ]. The occurrence of hyperglycemia, dyslipidemia, and hypertension in metabolic syndrome is associated with endothelial dysfunction and promotion of atherogenesis [ 3 ]. These changes show that patients with metabolic syndrome have an increased risk of myocardial infarction and stroke [ 4 , 5 ], which, together, contribute to the burden of non-communicable diseases [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Obese individuals often present with metabolic disorders, such as high blood pressure, elevated fasting glucose levels and lipid abnormalities, which promote vascular injury and endothelial dysfunction [ 6 ]. Highlighting the role of inflammation in obesity, adipose tissue from obese individuals is characterized by inflammation and can secrete humoral factors that regulate systemic acute-phase reactants, such as C-reactive protein (CRP) [ 7 , 8 ], as well as inflammatory factors, such as monocyte chemo-attractant protein-1 (MCP-1) [ 9 ], tumor necrosis factor-α (TNF-α) [ 10 ], and interleukin-6 (IL-6) [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…Insulin resistance is a major component of metabolic syndrome, i.e. a group of risk factors that generally occur together and increase the risk for various diseases, including type 2 diabetes mellitus and several other metabolic diseases (Campbell 2011, Karagiannis et al 2012, cerebrovascular and coronary artery diseases (Hadaegh et al 2012, Vykoukal & Davies 2012, neurodegenerative disorders (Kaidanovich-Beilin et al 2012, Talbot et al 2012, infectious diseases (Jeon et al 2012, Witso 2012, and cancer (Byers & Sedjo 2011, Spyridopoulos et al 2012. Due to the ongoing worldwide epidemic of obesity and other insulin resistance-related disorders (Campbell 2011), insulin-like peptides (ILPs), i.e.…”
Section: Introductionmentioning
confidence: 99%